FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023407130> ?p ?o ?g. }

• W2023407130 endingPage "462" @default.
• W2023407130 startingPage "455" @default.
• W2023407130 abstract "The effect of fenofibrate (FEN), compared with placebo (PL), on total plasma homocysteine (tHcy) levels in the fasted and fed states has been examined. Twenty men with established coronary artery disease (CAD) or with at least two cardiovascular risk factors, who had elevated plasma triglyceride levels (> 2.3 mmol/l) and reduced HDL-C levels (< 0.91 mmol/l), and in whom a fibric acid derivative was clinically indicated were studied. The study was a randomized, PL controlled, double-blind study designed to test the effect of micronized FEN on postprandial lipemia. Plasma tHcy levels were investigated as a post-hoc analysis. After a 4-week dietary stabilization period, patients were randomized to PL or FEN (200 mg/day) for 8 weeks, followed by an 8-h postprandial study, consisting of 1 g fat/kg body weight (35% cream). The methionine content of cream was approximately 0.53 mg/ml. A 5-week washout period was then followed by a second 8-week treatment period (FEN or PL), at the end of which a second postprandial study was undertaken. Blood was sampled in the fasted state (0 h) and postprandially at 2, 4, 6 and 8 h. Plasma was stored at -80 degrees C for homocysteine, vitamins B(6), B(12) and folate measurements. FEN caused a marked decrease in all triglyceride-rich lipoprotein parameters, no change in LDL-C, and an increase in HDL-C levels. Fen treatment was associated with an increase in fasting tHcy (PL: 10.3+/-3.3 micromol/l to FEN: 14.1+/-3.8 micromol/l, 40.4+/-20.5%, P < 0.001) and fed tHcy levels 6 h post-fat load (PL: 11.6+/-3.3 micromol/l vs. FEN: 17.1+/-5.4 micromol/l, P < 0.001). Homocysteine levels were increased by the fat load; PL: 14% (P < 0.001) and FEN: 21%, P < 0.001 at the 2, 4, 6 and 8 h time points. Change in tHcy level on FEN was not associated with changes in plasma levels of folate, vitamins B(6) or B(12) or creatinine. Amino acid analysis revealed that methionine and cysteine were significantly increased on FEN (P < 0.005). The incidence of hyperhomocysteinemia (defined as tHcy level >14 micromol/l) was PL: 2/20 (10%) and FEN: 9/20 (45%) (chi(2) = 4.51, P = 0.034). There was no correlation between changes in plasma triglyceride levels and tHcy levels. Since tHcy is considered an emerging cardiovascular risk factor, the ability of FEN to increase plasma tHcy levels could potentially mitigate the potential of this drug to protect against cardiovascular disease." @default.
• W2023407130 created "2016-06-24" @default.
• W2023407130 creator A5022102417 @default.
• W2023407130 creator A5023567192 @default.
• W2023407130 creator A5028603190 @default.
• W2023407130 creator A5042816112 @default.
• W2023407130 creator A5058992883 @default.
• W2023407130 creator A5059095877 @default.
• W2023407130 date "2001-04-01" @default.
• W2023407130 modified "2023-10-04" @default.
• W2023407130 title "Fenofibrate raises plasma homocysteine levels in the fasted and fed states" @default.
• W2023407130 cites W1549577793 @default.
• W2023407130 cites W1672804368 @default.
• W2023407130 cites W1767062481 @default.
• W2023407130 cites W1969800712 @default.
• W2023407130 cites W1977349752 @default.
• W2023407130 cites W1986416204 @default.
• W2023407130 cites W1987899716 @default.
• W2023407130 cites W1997722778 @default.
• W2023407130 cites W2003592725 @default.
• W2023407130 cites W2027665192 @default.
• W2023407130 cites W2029899407 @default.
• W2023407130 cites W2043705500 @default.
• W2023407130 cites W2046268728 @default.
• W2023407130 cites W2050878161 @default.
• W2023407130 cites W2071822385 @default.
• W2023407130 cites W2073908806 @default.
• W2023407130 cites W2084236626 @default.
• W2023407130 cites W2090730785 @default.
• W2023407130 cites W2095885613 @default.
• W2023407130 cites W2107611836 @default.
• W2023407130 cites W2108484297 @default.
• W2023407130 cites W2113103899 @default.
• W2023407130 cites W2118310760 @default.
• W2023407130 cites W2129750583 @default.
• W2023407130 cites W2143669999 @default.
• W2023407130 cites W2149244737 @default.
• W2023407130 cites W2151287401 @default.
• W2023407130 cites W2152789823 @default.
• W2023407130 cites W2155598961 @default.
• W2023407130 cites W2167744816 @default.
• W2023407130 cites W2317172136 @default.
• W2023407130 cites W2322095705 @default.
• W2023407130 cites W2328529137 @default.
• W2023407130 cites W2400712338 @default.
• W2023407130 cites W3145726055 @default.
• W2023407130 cites W38523360 @default.
• W2023407130 cites W4256578596 @default.
• W2023407130 cites W4361972733 @default.
• W2023407130 doi "https://doi.org/10.1016/s0021-9150(00)00584-0" @default.
• W2023407130 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11254917" @default.
• W2023407130 hasPublicationYear "2001" @default.
• W2023407130 type Work @default.
• W2023407130 sameAs 2023407130 @default.
• W2023407130 citedByCount "64" @default.
• W2023407130 countsByYear W20234071302013 @default.
• W2023407130 countsByYear W20234071302014 @default.
• W2023407130 countsByYear W20234071302015 @default.
• W2023407130 countsByYear W20234071302019 @default.
• W2023407130 countsByYear W20234071302020 @default.
• W2023407130 countsByYear W20234071302021 @default.
• W2023407130 crossrefType "journal-article" @default.
• W2023407130 hasAuthorship W2023407130A5022102417 @default.
• W2023407130 hasAuthorship W2023407130A5023567192 @default.
• W2023407130 hasAuthorship W2023407130A5028603190 @default.
• W2023407130 hasAuthorship W2023407130A5042816112 @default.
• W2023407130 hasAuthorship W2023407130A5058992883 @default.
• W2023407130 hasAuthorship W2023407130A5059095877 @default.
• W2023407130 hasConcept C126322002 @default.
• W2023407130 hasConcept C134018914 @default.
• W2023407130 hasConcept C142724271 @default.
• W2023407130 hasConcept C185592680 @default.
• W2023407130 hasConcept C204787440 @default.
• W2023407130 hasConcept C27081682 @default.
• W2023407130 hasConcept C2777090595 @default.
• W2023407130 hasConcept C2778110834 @default.
• W2023407130 hasConcept C2778163477 @default.
• W2023407130 hasConcept C2778199505 @default.
• W2023407130 hasConcept C2778913445 @default.
• W2023407130 hasConcept C2779306644 @default.
• W2023407130 hasConcept C71924100 @default.
• W2023407130 hasConcept C87813604 @default.
• W2023407130 hasConceptScore W2023407130C126322002 @default.
• W2023407130 hasConceptScore W2023407130C134018914 @default.
• W2023407130 hasConceptScore W2023407130C142724271 @default.
• W2023407130 hasConceptScore W2023407130C185592680 @default.
• W2023407130 hasConceptScore W2023407130C204787440 @default.
• W2023407130 hasConceptScore W2023407130C27081682 @default.
• W2023407130 hasConceptScore W2023407130C2777090595 @default.
• W2023407130 hasConceptScore W2023407130C2778110834 @default.
• W2023407130 hasConceptScore W2023407130C2778163477 @default.
• W2023407130 hasConceptScore W2023407130C2778199505 @default.
• W2023407130 hasConceptScore W2023407130C2778913445 @default.
• W2023407130 hasConceptScore W2023407130C2779306644 @default.
• W2023407130 hasConceptScore W2023407130C71924100 @default.
• W2023407130 hasConceptScore W2023407130C87813604 @default.
• W2023407130 hasIssue "2" @default.
• W2023407130 hasLocation W20234071301 @default.

• next